Boiron SA (EPA: BOI)
France
· Delayed Price · Currency is EUR
29.90
+0.15 (0.50%)
Nov 20, 2024, 5:35 PM CET
Boiron Revenue
Boiron had revenue of 228.35M EUR in the half year ending June 30, 2024, a decrease of -11.07%. This brings the company's revenue in the last twelve months to 481.71M, down -6.89% year-over-year. In the year 2023, Boiron had annual revenue of 493.25M, down -7.67%.
Revenue (ttm)
481.71M
Revenue Growth
-6.89%
P/S Ratio
1.08
Revenue / Employee
172.78K
Employees
2,810
Market Cap
519.13M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 493.25M | -40.99M | -7.67% |
Dec 31, 2022 | 534.24M | 79.04M | 17.36% |
Dec 31, 2021 | 455.20M | -58.38M | -11.37% |
Dec 31, 2020 | 513.58M | -43.54M | -7.82% |
Dec 31, 2019 | 557.13M | -47.09M | -7.79% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sanofi | 48.45B |
EssilorLuxottica Société anonyme | 25.83B |
Sartorius Stedim Biotech S.A. | 2.74B |
bioMérieux S.A. | 3.81B |
Ipsen S.A. | 3.44B |
Eurofins Scientific SE | 6.72B |
Virbac SA | 1.34B |
Ramsay Générale de Santé SA | 5.01B |